Cefuroxime 1.5 g/1 (Cefuroxime INJECTION, POWDER, FOR SOLUTION) 1.5 g/1

Cefuroxime 1.5 g/1 is an injectable antibiotic used to treat bacterial infections. This powder for solution is administered intravenously for systemic effects. Learn more about Cefuroxime uses and benefits.

Strength

1.5 g/1

Pack Size

25 VIAL in 1 CARTON (0143-9977-22) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0143-9977-90)

Manufacturer / TM Owner

Hikma Pharmaceuticals USA Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Cefuroxime 1.5 g/1 is a broad-spectrum antibiotic commonly used to treat various bacterial infections. It is often prescribed for respiratory tract infections, urinary tract infections, and skin infections. What is Cefuroxime used for? This medication is effective against a wide range of bacteria, making it a versatile option for intravenous administration.

Side Effects

Common effects of Cefuroxime may include mild gastrointestinal discomfort, such as nausea or diarrhea. Some individuals might experience allergic reactions, though these are less frequent. Always consult a healthcare provider for personalized advice regarding side effects.

Precautions & Warnings

Cefuroxime should be handled with care, ensuring proper storage and preparation. It is essential to follow healthcare provider instructions for administration. Individuals with known allergies to cephalosporins should exercise caution. Always inform your healthcare provider about any pre-existing conditions.

Avoid Interactions

Cefuroxime may interact with certain medications, including other antibiotics and blood thinners. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should be moderated while using this medication.

Frequently Asked Questions

Cefuroxime is used to treat a variety of bacterial infections, including respiratory, urinary, and skin infections.

Cefuroxime 1.5 g/1 is administered intravenously as a powder for solution.

Common side effects may include nausea, diarrhea, and allergic reactions.

Cefuroxime may interact with other medications, so it is important to consult a healthcare provider before combining treatments.

Individuals with allergies to cephalosporins should exercise caution and consult a healthcare provider.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.